ATM is frequently mutated or inactivated in a variety of tumors, including lung cancer, breast cancer, brain cancer,745 and pancreatic cancer.746 Endometrial cancer patients with ATM mutations exhibit a higher tumor mutational burden, a higher neoantigen load, and increased expression levels of immune checkpoints. Here, ATM is linked to endometrial cancer.